MedTrace Logo

L-carnitine and Metformin in Obese PCOS Women.

NCT03108963 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2018-05-02

No results posted yet for this study

Summary

L-carnitine and plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effect: a randomized clinical trial

Conditions

  • PCOS

Interventions

DRUG

L-carnitine and Metformin

L-carnitine plus Metformin was given Obese PCOS Women trying induction of ovulation with clomiphene citrate.

DRUG

placebo

placebo was given Obese PCOS Women trying induction of ovulation with clomiphene citrate.

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • ibrahim A el sharkwy, MD · FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03108963 on ClinicalTrials.gov